This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
May 24, 2012 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Allscripts Healthcare Solutions, Inc. ("Allscripts" or the "Company") (Nasdaq: MDRX).
The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) the process of developing a unified product offering after the Company's merger with Eclypsis was difficult and costly; (2) merger-related difficulties would cause upheaval and result in the loss of key Company personnel; and (3) substantial Company business had been destroyed by Allscripts' inability to successfully integrate Eclypsis' systems with its own.
April 26, 2012, Allscripts issued operating results for the first quarter of 2012 that were well below expected forecasts. The Company also announced the termination of the Chairman of the Board and the resignation of three Company directors and the Company's Chief Financial Officer. In light of these turbulent events, Allscripts' stock price fell
$5.72 per share, or 35.7 percent, to close at
$10.30 per share on
April 27, 2012.
Request more information now by clicking here:
If you purchased Allscripts securities between
November 9, 2010 and
April 26, 2012 and would like to discuss your legal rights, visit
www.faruqilaw.com/MDRX. You can also contact us by calling
Richard Gonnello or
Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to
email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Allscripts conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (
www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential matter.FARUQI & FARUQI, LLP369 Lexington Avenue, 10th Floor
New York, NY 10017Attn:
Richard Gonnello, Esq.firstname.lastname@example.orgFrancis McConville, Esq.email@example.comTelephone: (877) 247-4292 or (212) 983-9330
SOURCE Faruqi & Faruqi, LLP